Pre-empting cardiac crises

Analytics for Life, a technology company focused on analyzing biological signals, is forging a collaboration with Dr. Terence Ozolinš of the Department of Biomedical and Molecular Sciences at Queen’s University. Through Analytics for Life’s unique analysis of electrocardiographic signals, the collaboration with Dr. Ozolinš will help to improve detection of unwanted side effects of drugs causing functional cardiac defects in newborns and provide a better understanding of the long term effects of these defects.
To learn more about Analytics4Life, visit: